NCT02995096View on ClinicalTrials.gov

Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

23,124

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

March 31, 2019

Conditions
Liver Transplantation
Interventions
PROCEDURE

Pre-treatment

Non-transplantation pre-treatments prior to transplantation (e.g. radiofrequency ablation, transcatheter arterial chemoembolization)

DRUG

Sirolimus based immunosuppression

Immunosuppression regimens containing Sirolimus

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02995096 - Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter